ENMING JOSEPH SU
Pharmacy in Ann Arbor, MI
License number
Michigan 5304000876
Issued Date
Jul 14, 2011
Expiration Date
Jun 30, 2018
Category
Pharmacy
Type
CS - Research Lab
Address
Address
Ann Arbor, MI 48109
Personal information
See more information about ENMING JOSEPH SU at radaris.comName
Address
Phone
6518 Wisteria Trce APT 30, Ann Arbor, MI 48103
Ann Arbor, MI
6518 Wisteria Trce, Ann Arbor, MI 48103
Professional information
See more information about ENMING JOSEPH SU at trustoria.com
Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof To Modulate Lipid Metabolism
Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof To Modulate Lipid Metabolism
US Patent:
2010013, Jun 3, 2010
Filed:
Nov 23, 2009
Appl. No.:
12/624126
Inventors:
Daniel A. Lawrence - Ann Arbor MI, US
Cory Emal - Ann Arbor MI, US
Jacqueline Cale - Minneapolis MN, US
Enming J. Su - Ann Arbor MI, US
Mark Warnock - Brighton MI, US
Jeanne A. Cupp - Fenton MI, US
Cory Emal - Ann Arbor MI, US
Jacqueline Cale - Minneapolis MN, US
Enming J. Su - Ann Arbor MI, US
Mark Warnock - Brighton MI, US
Jeanne A. Cupp - Fenton MI, US
Assignee:
EASTERN MICHIGAN UNIVERSITY - Ypsilamti MI
International Classification:
A61K 38/16, C07C 69/76, A61K 31/235, C07C 233/64, A61K 31/166, C07D 401/12, A61K 31/444, C07D 241/04, A61K 31/4965, C07D 237/04, A61K 31/50, C07D 265/30, A61K 31/5375, C07D 311/00, A61K 31/351, C07H 15/203, A61K 31/7028, A61P 3/10, A61P 3/04, A61P 25/28, A61P 9/04, A61P 19/02
US Classification:
514 8, 560 76, 514533, 564158, 514616, 560 61, 546261, 514335, 544387, 51425501, 544224, 514247, 544158, 5142388, 549417, 514460, 536 182, 514 25
Abstract:
The invention relates to plasminogen activator-1 (PAI-1) inhibitor compounds and uses thereof in the treatment of any disease or condition associated with elevated PAI-1. The invention includes, but is not limited to, the use of such compounds to modulate lipid metabolism and treat conditions associated with elevated PAI-1, cholesterol, or lipid levels.
Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof To Modulate Lipid Metabolism
Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof To Modulate Lipid Metabolism
US Patent:
2009001, Jan 8, 2009
Filed:
Apr 16, 2008
Appl. No.:
12/104409
Inventors:
Daniel A. Lawrence - Ann Arbor MI, US
Dudley Strickland - Brookville MD, US
Jacqueline Cale - Ann Arbor MI, US
Enming J. Su - Ann Arbor MI, US
Cory Emal - Ann Arbor MI, US
Mark Warnock - Brighton MI, US
Dudley Strickland - Brookville MD, US
Jacqueline Cale - Ann Arbor MI, US
Enming J. Su - Ann Arbor MI, US
Cory Emal - Ann Arbor MI, US
Mark Warnock - Brighton MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 36/82, G01N 33/566, A61K 31/60, A61K 31/235, C07D 317/04, C07C 62/04, A61P 3/10, A61P 35/00, A61P 9/10, C07C 333/02, C07C 69/773, A61K 31/352, A61K 31/192, A61K 31/195
US Classification:
424729, 436501, 514166, 514532, 514570, 514563, 514568, 514456, 549417, 560 86, 562465, 560303
Abstract:
The invention relates to plasminogen activator-1 (PAI-1) inhibitor compounds and uses thereof in the treatment of any disease or condition associated with elevated PAI-1. The invention includes, but is not limited to, the use of such compounds to modulate lipid metabolism and treat conditions associated with elevated PAI-1, cholesterol, or lipid levels.
Methods And Compositions For Modulation Of Blood-Neural Barrier
Methods And Compositions For Modulation Of Blood-Neural Barrier
US Patent:
8147828, Apr 3, 2012
Filed:
Apr 17, 2007
Appl. No.:
11/736499
Inventors:
Ulf Eriksson - Stockholm, SE
Daniel Lawrence - Ann Arbor MI, US
Enming Joe Su - Ann Arbor MI, US
Dudley Strickland - Brookeville MD, US
Manuel Yepes - Atlanta GA, US
Linda Fredriksson - Hagersten, SE
Daniel Lawrence - Ann Arbor MI, US
Enming Joe Su - Ann Arbor MI, US
Dudley Strickland - Brookeville MD, US
Manuel Yepes - Atlanta GA, US
Linda Fredriksson - Hagersten, SE
Assignee:
Ludwig Institute for Cancer Research - New York NY
University of Maryland - Baltimore MD
The Regents of the University of Michigan - Ann Arbor MI
University of Maryland - Baltimore MD
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 39/395, C07K 16/28, C07K 14/71
US Classification:
4241301, 4241431, 5303871, 53038822
Abstract:
Methods and compositions for modulating blood-neural barrier (BNB) for the treatment of CNS conditions such as edema, and for increased drug delivery efficacy across the BNB. The present invention further relates to improved tPA treatment of ischemic cerebrovascular and related diseases in combination with antagonism of the PDGF signaling pathway. The inventive method and composition is particularly suitable for conjunctive therapy of ischemic stroke using tPA and an anti-PDGF-C antagonist or an anti-PDGFR-α antagonist.